ERBB2 and breast cancer: In oncology, FISH has become an essential diagnostic tool, not only for confirming structural rearrangements such as BCR::ABL1, MYC or ETV6::RUNX1 fusions, but also for detecting gene amplifications (e.g., HER2 in breast cancer) and chromosomal gains or losses that impact treatment decisions.